About Applied BioMath
Applied BioMath is a company based in Cambridge (United States) founded in 2013 was acquired by Certara in December 2023. Applied BioMath has raised $2.32 million across 10 funding rounds from investors including NIH, Certara and HHS. The company has 61 employees as of December 31, 2022. Applied BioMath offers products and services including Phoenix™, Pinnacle 21, and Simcyp™. Applied BioMath operates in a competitive market with competitors including Aqemia, NTxBio, Nimble Therapeutics, Enveda and IMIDomics, among others.
- Headquarter Cambridge, United States
- Employees 61 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Applied BioMath
Applied BioMath offers a comprehensive portfolio of products and services, including Phoenix™, Pinnacle 21, and Simcyp™.
Tool for PK, PD, and toxicokinetic analysis in drug development.
Platform for data standardization and validation in clinical trials.
Simulates drug behavior in populations for PBPK modeling.
People of Applied BioMath
Unlock access to complete
Unlock access to complete
Funding Insights of Applied BioMath
Applied BioMath has successfully raised a total of $2.32M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $299.99 thousand completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Applied BioMath
Applied BioMath has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, Certara and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked | |
|
Provider of a platform for in silico drug discovery and consulting services
|
Locked | Locked | Locked |
Investor details for Applied BioMath
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Applied BioMath
Investment portfolio details for Applied BioMath
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Applied BioMath
Detailed financials for Applied BioMath
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Applied Biomath Comparisons
Peer comparison for Applied BioMath
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Applied BioMath
Applied BioMath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aqemia, NTxBio, Nimble Therapeutics, Enveda and IMIDomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic molecules are discovered through AI and quantum physics integration.
|
|
| Locked | Locked | Locked |
Provider of bio informatics platform to develops biologics and therapeutics
|
|
| Locked | Locked | Locked |
Combinatorial chemistry services for peptide-based drug discovery are provided.
|
|
| Locked | Locked | Locked |
Provider of AI-based platform to decipher the chemistry of nature and develop new medicines
|
|
| Locked | Locked | Locked |
Precision medicines for immune-mediated inflammatory diseases are developed.
|
Detailed competitors of Applied BioMath
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Applied Biomath
Complete news archive for Applied BioMath
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Applied BioMath
Applied BioMath was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Applied BioMath is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Applied BioMath is a funded company, having raised a total of $2.32M across 10 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Applied BioMath is 61.
Applied BioMath, applies mechanistic modeling to drug development, helps biotechnology and pharmaceutical companies answer complex, critical GoNo-go decisions in RD. Applied BioMath leverages biology, proprietary mathematical modeling and analysis technology, high-performance computing, and to help groups better understand their candidate, its best-in-class parameters, competitive advantages, and the best path forward. They aim to shorten project timelines, lowers cost, and increases the likelihood of a best-in-class drug. Their service offering spans systems biology and pharmacology. Its systems biology services include pathway model development and analysis, new target discovery, biomarker discovery, and experiment design and prioritization; and systems pharmacology services include feasibility assessments for biologics and small molecule targets, analysis and differentiation of competitor compounds, predict drug properties, first in human dose projection, Phase 1 analysis, indication-specific dose projections, and identification of mechanistic covariates. The company also provides systems informatics services, including principal components analysis, partial least squares regression, cue-signal-response analysis, and Booleanfuzzy logic.
Applied BioMath offers Phoenix™, Pinnacle 21, and Simcyp™.